These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074 [TBL] [Abstract][Full Text] [Related]
26. Morbidity rates with reduced mycophenolate mofetil dosage: a single-center experience. Kaushik M; Kay MD; Bagul A; Nicholson ML Transplant Proc; 2006 Nov; 38(9):2864-5. PubMed ID: 17112850 [TBL] [Abstract][Full Text] [Related]
27. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. Tsai SF; Cheng CY; Shu KH; Wu MJ Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612 [TBL] [Abstract][Full Text] [Related]
28. Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience. Mastrobuoni S; Ubilla M; Cordero A; Herreros J; Rabago G Transplant Proc; 2007 Sep; 39(7):2163-6. PubMed ID: 17889125 [TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen. Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132 [TBL] [Abstract][Full Text] [Related]
30. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
31. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510 [TBL] [Abstract][Full Text] [Related]
32. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Wu JY; Chen JH; Wang YM; He Q; Wu DB Transplantation; 2004 Sep; 78(5):713-8. PubMed ID: 15371674 [TBL] [Abstract][Full Text] [Related]
33. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S; Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205 [TBL] [Abstract][Full Text] [Related]
34. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
35. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512 [TBL] [Abstract][Full Text] [Related]
36. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]